- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/31 - Somatostatins
Patent holdings for IPC class A61K 38/31
Total number of patents in this class: 290
10-year publication summary
|
19
|
32
|
20
|
24
|
25
|
24
|
29
|
19
|
22
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10856 |
24 |
| Camurus AB | 143 |
18 |
| Amryt Endo, Inc. | 50 |
17 |
| Ipsen Pharma S.A.S. | 375 |
9 |
| Salix Pharmaceuticals, Inc. | 82 |
7 |
| BCN Peptides, S.A. | 32 |
6 |
| Mondobiotech Laboratories AG | 311 |
6 |
| Otsuka Pharmaceutical Co., Ltd. | 1500 |
6 |
| The Scripps Research Institute | 1348 |
6 |
| Rani Therapeutics, LLC | 199 |
5 |
| Amryt Endo, Inc. | 6 |
5 |
| Mayo Foundation for Medical Education and Research | 3202 |
4 |
| Glytech, Inc. | 65 |
4 |
| Recordati AG | 41 |
4 |
| Nbo Pharma Inc. | 4 |
4 |
| Evonik Corporation | 80 |
3 |
| Antisense Therapeutics Ltd. | 29 |
3 |
| Debiopharm International SA | 131 |
3 |
| Italfarmaco SpA | 147 |
3 |
| New York University | 1743 |
3 |
| Other owners | 150 |